INTEGRATIVE & ALTERNATIVE ONCOLOGY
Alternative Cancer Treatment
A More Individualized Approach to Complex Cancer Care
Individualized physician-directed cancer care for newly diagnosed, recurrent, metastatic and Stage 4 cancer.
At Sunridge Medical, we take a broader view of cancer treatment. We review the biology of the cancer, what has already been tried, available pathology and molecular information, the patient’s current health, and which integrative strategies may reasonably fit the case.
Patients come to us before treatment begins, while receiving chemotherapy, radiation, immunotherapy or targeted therapy, after treatment, at recurrence, with Stage 4 disease, or when they want to explore another treatment path.
STAGE 4 & ADVANCED CANCER
Patients come to Sunridge with metastatic disease, recurrence, treatment resistance and previous therapy histories that may require a more individualized strategy.
✓ Multiple previous treatments
✓ Treatment resistance or progression
✓ Patients seeking additional options
Stage 4 Cancer Does Not Mean We Stop Looking for Options
A Stage 4 diagnosis can change the conversation quickly. Some patients arrive while still receiving active systemic treatment. Others have progressed through several lines of therapy and feel that the list of choices is getting shorter.
That is when a careful re-review of the whole case can matter.
We look at the type and biology of the cancer, where it has spread, previous treatments and responses, available molecular information, current blood counts and organ function, treatment tolerance, and what the patient wants from the next phase of care.
Updated pathology and biomarker information
Previous treatment response and resistance
Remaining standard and clinical-trial options
Physician-directed integrative strategies
Quality of life and treatment tolerance
We do not assume that every Stage 4 patient needs the same program. The question is what vulnerabilities can still be identified, what treatments remain reasonable, and how we can support the patient while continuing to address the cancer.
YOUR CANCER JOURNEY
You Can Come to Sunridge at Any Point
There is no single “correct” moment to begin integrative oncology. The role of Sunridge changes depending on where you are in the cancer journey.
Before Conventional Treatment
Review the diagnosis, understand available options and begin building an individualized integrative plan before treatment starts.
During Conventional Treatment
Coordinate physician-directed integrative care around chemotherapy, radiation, immunotherapy or targeted therapy when clinically appropriate.
After Conventional Treatment
Focus on recovery, rebuilding strength, treatment-related effects, ongoing monitoring and a longer-term health strategy.
When You Want Another Path
If standard options have become limited—or you have chosen not to pursue a recommended treatment—we can review the case and discuss what physician-directed alternatives may reasonably be considered.
WHY SUNRIDGE
Why Patients Choose Sunridge Medical for Cancer Care
A different approach does not have to mean a less serious approach. We believe integrative oncology should be personalized, active, medically supervised and willing to ask more questions.
We Look Beyond a Single Treatment
Cancer care should involve more than choosing one isolated therapy. We review the diagnosis, previous treatment, relevant tumor biology, current health and the broader clinical picture.
Treatment Is Individualized
Stage, pathology, molecular findings, previous response, medications, organ function, treatment tolerance and the patient's goals can all influence the treatment strategy.
Natural Medicine Is Active Medicine
Botanical, nutritional, metabolic and redox therapies can have real biological effects. That is why we believe they should be selected thoughtfully and used with medical supervision.
We Can Work Around Existing Oncology Care
Many patients continue chemotherapy, radiation, immunotherapy or targeted therapy with an outside oncology team while receiving coordinated integrative care at Sunridge.
Advanced & Complex Cases Are Welcome
Metastatic, recurrent and heavily treated cancers deserve careful evaluation rather than being dismissed simply because the case has become difficult.
We Keep Reassessing
Cancer changes. Treatment response changes. The patient's condition changes. A serious treatment plan should be capable of changing with the clinical picture.
A CLINICAL FRAMEWORK
A Cancer Program Built Around Four Questions
The goal is to connect tumor biology with whole-person physiology and then keep reassessing the plan as the clinical picture changes.
What Is Driving the Cancer?
We begin with the diagnosis itself: cancer type, stage, pathology, location of disease, growth pattern, molecular information and the history of how the cancer has responded to previous treatment.
What Is Happening in the Body?
Laboratory findings, nutritional status, metabolism, inflammation, organ function, symptoms, medications and treatment tolerance help us understand the physiological environment surrounding the cancer.
What Can We Reasonably Target?
We consider which conventional, integrative, metabolic, botanical, nutritional or other physician-directed strategies make sense for the cancer biology and the patient's current treatment situation.
How Is the Patient Responding?
Symptoms, laboratory data, imaging when available, treatment tolerance and changes in the clinical picture help determine whether the plan should continue, intensify, change or simplify.
The treatment plan is not static. Cancer biology can change, resistance can develop and the patient's condition can improve or decline. Reassessment is therefore part of the treatment strategy—not an afterthought.
SCIENCE + NATURAL MEDICINE
Natural Medicine Should Be Taken Seriously
Choosing natural medicine should not mean abandoning scientific discipline. Natural compounds can be biologically active—and that is exactly why they should be selected deliberately.
At Sunridge, the questions are the same ones we would want asked of any therapy:
What Is the Biological Rationale?
Is there a credible mechanism that makes the therapy relevant to this cancer or treatment objective?
What Does the Research Show?
We distinguish human clinical evidence from animal studies, laboratory findings and theoretical mechanisms.
What Dose and Route Make Sense?
A compound taken orally may behave differently from one used intravenously or at pharmacologic concentrations.
Could It Interact With Treatment?
Chemotherapy, radiation, immunotherapy, endocrine therapy and targeted drugs all require consideration.
What Are We Trying to Accomplish?
Tumor biology, treatment support, metabolism, inflammation and quality of life are different objectives.
How Will We Reassess?
Symptoms, laboratory findings, imaging and treatment tolerance help determine whether the strategy should continue or change.
Natural therapies should be evaluated for mechanism, clinical evidence, dose, route, safety, interactions and a clearly defined treatment objective.
TREATMENT FAMILIES
Integrative Cancer Treatment Areas
Cancer treatment is rarely about one isolated therapy. At Sunridge Medical, treatments may be selected from several different categories depending on the cancer, previous treatment, current medications, laboratory findings, treatment goals and the patient’s overall condition.
The purpose is not to use every available therapy. It is to determine which combination makes the most sense for the individual case.
IV & Nutrient-Based Therapies
Physician-directed intravenous therapies may be incorporated when the route, concentration and clinical objective make IV administration appropriate.
Botanical & Natural Therapies
Naturally derived compounds can influence cellular signaling, metabolism, oxidative stress, hormone pathways and other processes relevant to cancer research.
Oxidative & Redox Therapies
Selected therapies are designed around redox signaling, cellular stress responses, circulation and related physiological pathways.
Metabolic Cancer Strategies
Cancer cells frequently demonstrate altered energy metabolism. Metabolic strategies examine these differences alongside the patient's nutritional and physiological status.
Immune & Biological Strategies
Cancer and immune function are closely interconnected. Integrative strategies may be considered in the context of the patient's immune status and existing oncology treatment.
Supportive Oncology
Treating cancer also means paying attention to how the patient is functioning during and after treatment.
DIAGNOSTICS & PERSONALIZATION
The First Step Is Understanding the Cancer Well Enough
Personalized cancer care starts with understanding what we are actually treating.
At Sunridge Medical, we review the information already available—pathology, stage, imaging, previous treatments, laboratory findings and relevant molecular or biomarker testing—before deciding which integrative strategies may make sense.
The more accurately we understand the cancer and the patient, the more intelligently treatment can be selected.
What Type of Cancer Is It?
Pathology helps establish the diagnosis, tumor type, grade and other characteristics that influence how the cancer is expected to behave.
Where Is the Disease?
Imaging and staging help define tumor burden, metastatic sites, progression patterns and the overall clinical picture.
What Has Already Been Tried?
Previous surgery, chemotherapy, radiation, immunotherapy, targeted therapy and treatment response provide important information about the next strategy.
Does the Tumor Have Actionable Features?
Molecular and biomarker testing may identify genes, proteins or other tumor characteristics that help guide treatment decisions.
How Is the Patient Functioning?
Blood counts, kidney and liver function, nutritional status, metabolism, inflammation and treatment tolerance can affect what therapies are appropriate.
What Are We Trying to Accomplish?
Treatment goals may include tumor response, slowing progression, supporting active oncology treatment, recovery or improving quality of life.
Integrative care should not ignore modern oncology information. Pathology, imaging and molecular data can make an integrative treatment plan more—not less—individualized.
DURING ACTIVE ONCOLOGY
Already Receiving Chemotherapy, Radiation, Immunotherapy or Targeted Therapy?
You do not necessarily have to wait until conventional cancer treatment is finished to begin integrative care.
Many patients come to Sunridge while an outside oncology team is actively treating the cancer. In that setting, our role is to understand the current oncology plan, review potential interactions, identify appropriate supportive or adjunctive strategies, and coordinate timing around treatment cycles, laboratory results and the patient’s changing condition.
Integrative care should work with the clinical situation—not ignore it.
Coordination matters especially with immunotherapy, targeted drugs and therapies whose effectiveness or toxicity may be affected by metabolism, immune signaling or redox-active compounds.
Understand the Oncology Plan
We review the drugs, radiation schedule, immunotherapy, targeted therapy or other treatment the patient is currently receiving.
Review Potential Interactions
Natural compounds, antioxidants, herbs and other therapies may have effects that matter during active cancer treatment, so timing and compatibility deserve attention.
Support Treatment Tolerance
Fatigue, neuropathy, appetite, nausea, sleep, nutritional status and recovery can become important parts of the integrative plan.
Reassess as Treatment Changes
Blood counts, organ function, treatment response and side effects can change from cycle to cycle, so the integrative plan may need to change too.
Coordination Matters
Integrative treatment is not automatically appropriate simply because it is natural. Chemotherapy, radiation, immunotherapy, endocrine therapy and targeted drugs can each create different considerations. The goal is to select therapies that make sense for the patient’s current treatment environment.
WHEN YOU WANT ANOTHER PATH
What If You Do Not Want the Treatment That Was Recommended?
Some patients come to Sunridge because they have decided they do not want surgery, chemotherapy, radiation or another recommended treatment. Others arrive after toxicity, progression or previous treatment experiences have changed what they are willing to pursue.
You can still request a consultation.
Our role is to understand your diagnosis, review what has been recommended, listen to your priorities and discuss what physician-directed integrative or alternative options may reasonably be considered.
We also believe an informed decision requires understanding when a conventional treatment has meaningful evidence for cure, survival or disease control. Choosing another path should be a deliberate medical decision—not simply a reaction to fear or frustration.
WHEN OPTIONS FEEL LIMITED
What If You've Been Told There Is Nothing More to Do?
There are situations in which standard oncology options become limited because the cancer has progressed through treatment, developed resistance, or because the expected benefit of another conventional therapy has become small.
That does not mean the case no longer deserves careful review.
A broader reassessment may include what has already been tried, why treatment stopped working, whether the biology of the cancer may have changed, whether updated pathology or biomarker information could reveal another target, what conventional or clinical-trial possibilities remain, and which integrative strategies may still be reasonable.
Has the Cancer Changed?
Cancer can evolve under treatment pressure. Updated pathology, imaging or molecular information may sometimes provide a different picture than what was available earlier in the disease course.
Why Did Previous Treatment Stop Working?
Understanding previous response, duration of benefit and progression patterns can help clarify which treatment pathways may still be worth considering.
Are There Additional Conventional or Trial Options?
A broader review may include remaining standard therapies, targeted options, clinical trials and updated biomarker-directed possibilities.
What Integrative Approaches Still Make Sense?
Metabolic, botanical, nutritional, redox, immune-supportive and other physician-directed strategies may be considered according to the patient’s current condition and treatment goals.
The Goal Can Change Without Giving Up
Sometimes the goal is tumor response. Sometimes it is slowing progression. Sometimes it is rebuilding strength so another treatment becomes possible. Sometimes quality of life becomes the highest priority. A serious cancer plan should be able to adapt as the clinical situation changes.
What Benefit Is the Standard Treatment Expected to Provide?
Before declining a treatment, it is useful to understand whether its purpose is cure, reducing recurrence risk, slowing progression, shrinking disease or relieving symptoms.
What Matters Most to You?
Treatment decisions can be influenced by quality of life, previous toxicity, age, other medical conditions, treatment burden and the patient’s individual goals.
What Other Options Are Reasonable?
We can review integrative approaches, remaining conventional choices, possible clinical trials and other physician-directed strategies in the context of the individual cancer.
If You Choose Another Path, Make It Deliberate
A serious alternative strategy should still have defined treatment goals, medical supervision, appropriate monitoring and a plan for reassessment.
You Are Still Welcome at Sunridge
You do not have to agree to every conventional recommendation before speaking with us. We can review the case, discuss your goals and help you understand what integrative and alternative approaches may be reasonable—while being clear about what is known, what is uncertain and where delaying an effective treatment could carry meaningful risk.
Talk With Our Cancer Patient Care Team →CANCERS WE TREAT
Cancer-Specific Care and Research
Cancer is not one disease, and different cancers can require very different treatment strategies.
Explore cancer-specific information about diagnosis, tumor biology, conventional treatment options, advanced disease and physician-directed integrative cancer care at Sunridge Medical.
Breast Cancer
Integrative care for hormone receptor-positive, HER2-positive, triple-negative, recurrent and metastatic breast cancer.
Explore Breast Cancer →Lung Cancer
Individualized care for non-small cell, small cell, recurrent and metastatic lung cancer.
Explore Lung Cancer →Prostate Cancer
Care informed by stage, PSA, pathology, imaging, hormone status and previous treatment.
Explore Prostate Cancer →Colon & Colorectal Cancer
Integrative strategies for localized, recurrent and metastatic colorectal cancer.
Explore Colorectal Cancer →Pancreatic Cancer
A comprehensive approach to resectable, locally advanced and metastatic pancreatic cancer.
Explore Pancreatic Cancer →Stage 4 & Metastatic Cancer
Advanced cancer care for patients with metastatic disease, progression or limited remaining treatment options.
Explore Stage 4 Cancer →Brain Cancer
Individualized evaluation for primary brain tumors and complex advanced brain cancer cases.
Explore Brain Cancer →Liver Cancer
Integrative care for primary liver cancer and complex cancers involving the liver.
Explore Liver Cancer →Ovarian Cancer
Personalized integrative care for newly diagnosed, recurrent and advanced ovarian cancer.
Explore Ovarian Cancer →Lymphoma
Individualized care for patients navigating lymphoma, previous treatment and recurrence.
Explore Lymphoma →Melanoma
Integrative care considered alongside modern systemic and immune-based melanoma treatment.
Explore Melanoma →Bladder Cancer
Cancer-specific review for non-muscle-invasive, muscle-invasive, recurrent and metastatic disease.
Explore Bladder Cancer →ALTERNATIVE CANCER TREATMENT RESEARCH
Explore the Research Behind Integrative Cancer Therapies
Patients frequently ask us about vitamin C, mistletoe, artemisinin, ozone, antioxidants and other natural or integrative cancer therapies.
Rather than treating these therapies as interchangeable, we examine them individually: what biological pathways have been studied, what human evidence exists, how the therapy is administered, what clinical objective it may serve and how it fits into the patient’s overall treatment strategy.
Explore some of the treatment and research areas used in physician-directed integrative cancer care at Sunridge Medical.
High-Dose Vitamin C
Explore the research surrounding pharmacologic intravenous vitamin C, its biological mechanisms, clinical investigation and its potential role within an individualized integrative oncology program.
Mistletoe Extract
Review research on standardized mistletoe preparations, including investigations involving quality of life, treatment tolerance, immune effects and cancer-supportive care.
Artemisinin & Cancer
Learn about artemisinin derivatives, iron-dependent cellular mechanisms and the laboratory and clinical research that has led to continued investigation in oncology.
Alpha-Lipoic Acid
Explore alpha-lipoic acid research involving mitochondrial biology, oxidative stress, redox regulation and its potential supportive applications within integrative care.
Ozone & Autohemotherapy
Learn about medical ozone and autohemotherapy, redox signaling, circulation and the biological concepts that have led to its use within physician-directed integrative medicine.
Glutathione IV
Explore glutathione biology, cellular antioxidant systems, redox balance and the questions surrounding its use during cancer treatment and recovery.
Explore the Full Treatment Research Library
Review additional IV therapies, botanical compounds, metabolic strategies, oxidative therapies and individualized cancer-treatment approaches.
PATIENT EXPERIENCE
Complex Cancer Care Is Also About How the Patient Is Doing
Cancer treatment decisions are medical, but the experience of treatment is deeply personal. Patients often arrive with fatigue, fear, previous treatment toxicity, uncertainty and a long list of unanswered questions.
We want patients to understand the treatment strategy, know why each therapy is being considered and have a medical team willing to keep reassessing the case as it evolves.
Treating the cancer matters. So does helping the patient remain strong enough—physically and emotionally—to continue making informed decisions about care.
Understand the Plan
Patients should know what is being recommended, why it is being considered and what the treatment is intended to accomplish.
Pay Attention to the Patient
Energy, appetite, sleep, nutrition, pain, neuropathy, treatment tolerance and quality of life can all influence the overall plan.
Keep Reassessing
The patient's condition and the cancer can change. Treatment should be reviewed as new information, symptoms and responses emerge.
Hear From Patients Who Have Come to Sunridge
Read patient experiences and learn more about what it is like to pursue individualized cancer care at Sunridge Medical.
BECOMING A PATIENT
What Happens When You Contact Sunridge?
You do not need to have every answer before contacting us. Many patients reach out while they are still trying to understand their diagnosis, treatment recommendations or remaining options.
Our Patient Care Team can help you determine what information is needed and what the next step would look like.
Tell Us About Your Situation
Contact our Patient Care Team and tell us your diagnosis, where you are in treatment and what you are hoping to explore. You do not need to have all of your records organized before making the first call.
Gather the Important Records
Pathology, imaging, laboratory results, treatment history and molecular testing can help us better understand the cancer before or around the physician consultation.
Discuss the Case in Detail
The consultation focuses on the diagnosis, previous treatments, current oncology plan, patient health, treatment goals and which integrative approaches may reasonably fit the situation.
Build the Treatment Plan
When appropriate, an individualized program can be developed around the cancer, the patient's condition, existing treatment and the objectives identified during the evaluation.
What Records Are Helpful?
Do not delay contacting us because you are missing something. The Patient Care Team can help identify which records are most useful for your particular case.
✓ Recent CT, PET, MRI or other imaging reports
✓ Recent laboratory results
✓ Current medications and supplements
✓ Chemotherapy or radiation treatment history
✓ Molecular or biomarker testing, if available
You Can Start With a Conversation
Whether you are newly diagnosed, currently in treatment, facing recurrence or living with Stage 4 cancer, our Patient Care Team can help you understand the next step.
Questions Patients Ask Before Coming to Sunridge
Patients often want to know when to come, whether Stage 4 disease can still be evaluated, and how integrative care may fit before, during or after conventional oncology treatment.
Do you treat Stage 4 cancer?
Yes. Patients with metastatic, recurrent and heavily treated cancers can be evaluated. The goals and appropriate therapies depend on the cancer, previous treatment, current condition and available options.
Can I come to Sunridge while receiving chemotherapy, radiation or immunotherapy?
Yes. Many patients seek integrative care during active oncology treatment. Potential interactions and treatment timing should be reviewed carefully before adding therapies.
Can I come before conventional treatment starts?
Yes. A consultation can help you understand the diagnosis, review available information and plan integrative care around upcoming treatment.
What if I have finished conventional treatment?
Post-treatment care may focus on recovery, persistent side effects, nutritional and metabolic status, laboratory monitoring and a longer-term health strategy.
What if I do not want the conventional treatment that was recommended?
You can still request a consultation. We will review your goals and discuss integrative options, while also making sure you understand when a standard treatment has established survival or curative benefit so that your decision is informed.
What if my cancer has progressed through several treatments?
Progression after multiple treatments can narrow options, but it does not eliminate the value of a careful re-review. Updated pathology, biomarker information, remaining standard options, clinical trials and integrative strategies may all be relevant.
Do you work with my oncologist?
Many Sunridge patients maintain relationships with outside oncologists. Coordination is particularly important when integrative therapies are being used around chemotherapy, targeted therapy, radiation or immunotherapy.
Do patients travel from outside Arizona?
Yes. Sunridge Medical is located in Scottsdale, Arizona, and patients travel from other states and countries for consultation and treatment.
What records should I provide?
Pathology, operative reports, imaging reports, recent laboratory work, molecular or biomarker testing, current medications and a treatment timeline are especially useful.
What is the difference between complementary, alternative and integrative cancer care?
Complementary care is used alongside conventional oncology treatment. Alternative care is used in place of standard treatment. Integrative care aims to coordinate appropriate evidence-informed supportive and biologically relevant therapies within the overall plan of care.
You Deserve a Cancer Plan Built Around Your Situation
Whether you are newly diagnosed, in active treatment, living with Stage 4 cancer, recovering after treatment or exploring a different approach, our Patient Care Team can help you understand the next step.
EVIDENCE & SOURCES
Selected References
- National Cancer Institute. Complementary and Alternative Medicine (CAM). NCI distinguishes complementary, alternative and integrative approaches and provides cancer-specific CAM resources.
- National Cancer Institute. Biomarker Testing for Cancer Treatment. Biomarker testing can provide information about genes, proteins and other tumor features relevant to treatment selection.
- Gowin K, et al. Integrative Therapies in Cancer Care: An Update on the Guidelines. ASCO Educational Book. 2024.
- National Cancer Institute. Alternative Medicine for Cancer Treatment Raises Mortality Risk. NCI summary of observational survival research.
Speak With Our Cancer Patient Care Team
Tell us where you are in your cancer journey. Our Patient Care Team can answer questions and help determine the next step.
Stage 4 Cancer?
Learn how Sunridge approaches metastatic, recurrent and heavily treated cancer cases.
Explore Stage 4 Cancer Care →Already in Treatment?
Integrative care may be coordinated around chemotherapy, radiation, immunotherapy or targeted therapy when appropriate.
Explore Integrative Cancer Therapy Research
Go deeper into melatonin, mistletoe, alpha-lipoic acid, artemisinin and other integrative oncology research.
View Treatment Research →